American Healthcare REIT, Inc.

Valuation Analysis

About the Company

American Healthcare REIT, Inc., a Maryland-based self-managed REIT, owns and operates a diversified portfolio of clinical healthcare real estate across the U.S., U.K., and the Isle of Man. Its focus includes senior housing, skilled nursing facilities (SNFs), outpatient medical (OM) buildings, and other healthcare-related properties. The company utilizes a fully integrated management platform and operates senior housing under the RIDEA structure. In addition to owning and operating properties, it has originated and acquired secured loans and may pursue other real estate-related investments opportunistically. The REIT seeks income-generating assets and selectively develops healthcare properties. It has elected to be taxed as a REIT under the U.S. Internal Revenue Code and intends to maintain

American Healthcare REIT, Inc. Stock at a Glance

American Healthcare REIT, Inc. (AHR) is currently trading at $46.81 with a market capitalization of $9B. The trailing P/E ratio stands at 79.34x, with a forward P/E of 54.43x. The 52-week range spans from $34.86 to $54.67; the current price is 14.4% below the yearly high. Year-over-year revenue growth stands at +20.9%. The net profit margin stands at 4.23%.

💰 Dividend

American Healthcare REIT, Inc. pays an annual dividend of $1.00 per share, representing a yield of 2.14%. The payout ratio stands at 169.49%. The elevated payout ratio reflects a mature dividend policy.

📊 Analyst Rating

13 analysts rate American Healthcare REIT, Inc. (AHR) on consensus: Buy. The average price target is $58.85, implying +25.71% from the current price. Analyst price targets range from $55.00 to $67.00.

American Healthcare REIT, Inc.: The Investment Case in Detail

American Healthcare REIT, Inc. (AHR) operates in the Real Estate — specifically REIT - Healthcare Facilities — and is headquartered in United States. Below is a structured read of the investment case built directly from the latest fundamentals, valuation multiples, analyst positioning and smart-money flows. Each section translates raw numbers into the investment logic they imply, so you can decide whether the risk/reward fits your portfolio.

The Bull Case

Revenue is growing at a healthy 20.9% pace year-over-year, suggesting the business model continues to find new customers and pricing power. Wall Street consensus sits at Buy with an average price target implying roughly 25.71% upside from current levels — analyst sentiment is firmly constructive.

The Bear Case

With a net margin of just 4.23%, the business has little room to absorb cost shocks or pricing pressure — a single bad quarter can swing the company to a loss. Our valuation screen flags the stock as overvalued — current multiples imply the business needs to deliver well above its recent trajectory to justify the price.

Valuation in Context

The EV/EBITDA multiple of 25.55x reflects rich expectations — historically, multiples at this level have proven hard to maintain for more than a few quarters.

What to Watch Next

• The forward P/E of 54.43x is meaningfully below the trailing 79.34x — analysts expect earnings to step up; the next earnings release is the test.
• The analyst consensus price target implies 25.71% upside — if the next two quarters confirm the underlying thesis, target hikes typically follow.

Investment Thesis: Strengths & Weaknesses

Technical Snapshot

The price is in a transition zone relative to the moving averages — no clear signal.

Risk Profile

The data points to relatively defensive market behavior, elevated short interest (8.24%).

Trading Data

💵 Dividend Info

Related Stocks in the Same Sector

Where can I buy American Healthcare REIT, Inc.?

Compare top-rated brokers — low fees, trusted providers, fully regulated.